Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases

Background Our aim is to report treatment efficacy and toxicity of patients treated by robotic (Cyberknife®) stereotactic body radiotherapy (SBRT) for oligorecurrent lung metastases (ORLM). Additionally we wanted to evaluate influence of tumor, patient and treatment related parameters on local control (LC), lung and distant progression free- (lung PFS/Di-PFS) and overall survival (OS). Methods Consecutive patients with up to 5 ORLM (confirmed by...